Stay updated on IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check27 days agoChange DetectedAn NIH transition notice was added, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.SummaryDifference0.6%

- Check34 days agoChange DetectedThe footer’s ClinicalTrials.gov software revision changed from v3.7.1 to v3.7.2. The study record content remains unchanged.SummaryDifference0.1%

- Check41 days agoChange DetectedThe ClinicalTrials.gov site revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check62 days agoChange DetectedA new revision entry v3.7.0 appears in the history, replacing the previous v3.6.6. This indicates an update to the page's revision-tracking mechanism rather than changes to the study details.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded revision v3.6.6 to the study's record history, reflecting an update to the page's versioning. The previous revision v3.6.5 is no longer listed in the current history.SummaryDifference0.1%

Stay in the know with updates to IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Regimen + Nivolumab in Solid Tumors Clinical Trial page.